Pages that link to "Q33897568"
Jump to navigation
Jump to search
The following pages link to Locally advanced, unresectable non-small cell lung cancer: new treatment strategies (Q33897568):
Displaying 14 items.
- Adjuvant and neoadjuvant treatments for NSCLC. (Q35024739) (← links)
- A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer. (Q35033439) (← links)
- Curcumin and lung cancer--a review (Q38212780) (← links)
- Physician over-recommendation of mammography for terminally ill women (Q42605394) (← links)
- Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model (Q42659931) (← links)
- Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection (Q45884517) (← links)
- A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer (Q46801438) (← links)
- Low-Dose Weekly Docetaxel Is as Tolerable as Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer (Q51043526) (← links)
- Identification of radiation-induced EndMT inhibitors through cell-based phenomic screening (Q60912525) (← links)
- Study on the expression of p53 and MMP-2 in patients with lung cancer after interventional therapy. (Q64944315) (← links)
- Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada (Q79186097) (← links)
- Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency (Q80473351) (← links)
- A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models (Q92826019) (← links)
- Dietary flavonoid myricetin inhibits invasion and migration of radioresistant lung cancer cells (A549-IR) by suppressing MMP-2 and MMP-9 expressions through inhibition of the FAK-ERK signaling pathway (Q93199155) (← links)